Transforming our business
Novartis announces portfolio transformation, focusing company on leading businesses with innovation power and global scale: Pharmaceuticals, Eye Care and Generics
Horsham update â€“ PharmaVentures hired to look at science park
Following the announcement in February of the closure of the Horsham site, we provide an update on proposed plans for the site here.
Novartis UK discloses payments in connection with sponsorship, grants and services
In line with ABPI Code requirements, the Pharmaceuticals and Vaccines divisions of Novartis today published sponsorship, grants and service payments made in 2013. Full details here, together with updated patient group listing for support provided in 2013.
UK recommends Novartis BexseroÂ® vaccine for inclusion in National Immunisation Programme to help protect against devastating Meningitis B
Following further review of evidence, JCVI recommends routine vaccination of infants against Meningitis B, the leading cause of meningitis in the UK.1,2 Learn more here.